These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26651959)

  • 1. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitroflow LXA structural deterioration following aortic valve replacement: a single-center experience.
    Zannis K; Diplaris K; Monin JL; Khelil N; Debauchez M; Dervanian P; Lansac E; Czirom D; Noghin M; Mankoubi L; Amabile N
    J Cardiovasc Surg (Torino); 2018 Oct; 59(5):746-752. PubMed ID: 29786406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.
    Sénage T; Le Tourneau T; Foucher Y; Pattier S; Cueff C; Michel M; Serfaty JM; Mugniot A; Périgaud C; Carton HF; Al Habash O; Baron O; Roussel JC
    Circulation; 2014 Dec; 130(23):2012-20. PubMed ID: 25355912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stentless vs Stented Aortic Valve Bioprostheses in the Small Aortic Root.
    Wollersheim LW; Li WW; Kaya A; Bouma BJ; Driessen AH; van Boven WJ; van der Meulen J; de Mol BA
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):390-397. PubMed ID: 28043449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age.
    Christ T; Grubitzsch H; Claus B; Konertz W
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):264-9. PubMed ID: 23158257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do differences in early hemodynamic performance of current generation biologic aortic valves predict outcomes 1 year following surgery?
    Thalji NM; Suri RM; Michelena HI; Greason KL; Dearani JA; Daly RC; Joyce LD; Stulak JM; Burkhart HM; Li Z; Schaff HV
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):163-73.e2. PubMed ID: 25439772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly.
    Alvarez JR; Sierra J; Vega M; Adrio B; Martinez-Comendador J; Gude F; Martinez-Cereijo J; Garcia J
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):842-6. PubMed ID: 19679611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: Results of a multicenter study.
    Rubino AS; Santarpino G; De Praetere H; Kasama K; Dalén M; Sartipy U; Lahtinen J; Heikkinen J; Deste W; Pollari F; Svenarud P; Meuris B; Fischlein T; Mignosa C; Biancari F
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):865-71; discussion 871. PubMed ID: 24954175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sorin freedom stentless pericardial valve: clinical and echocardiographic performance at 10 years.
    Milano AD; Dodonov M; Celiento M; Pizzuti M; Golia G; Faggian G; Bortolotti U; Mazzucco A
    Int J Artif Organs; 2012 Jul; 35(7):481-8. PubMed ID: 22661113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction.
    Ius F; Schulz J; Roumieh M; Fleissner F; Ismail I; Tudorache I; Warnecke G; Martens A; Shrestha M; Boethig D; Haverich A; Cebotari S
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):264-271. PubMed ID: 28838100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated aortic valve replacement in patients with small aortic annulus-a high-risk group on long-term follow-up.
    Wilbring M; Alexiou K; Schumann E; Matschke K; Tugtekin SM
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):379-85. PubMed ID: 23258763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
    Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
    J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position.
    Anselmi A; Flécher E; Ruggieri VG; Harmouche M; Langanay T; Corbineau H; Verhoye JP; Leguerrier A
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1884-91. PubMed ID: 23988288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication.
    Sénage T; Gillaizeau F; Le Tourneau T; Marie B; Roussel JC; Foucher Y
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1383-1390.e5. PubMed ID: 30415900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.
    Mosquera VX; Bouzas-Mosquera A; Velasco-García C; Muñiz J; Estévez-Cid F; Portela-Torron F; Herrera-Noreña JM; Cuenca-Castillo JJ
    J Card Surg; 2016 May; 31(5):264-73. PubMed ID: 26991888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic performance of Trifecta: single-center experience of 400 patients.
    Modi A; Budra M; Miskolczi S; Velissaris T; Kaarne M; Barlow CW; Livesey SA; Ohri SK; Tsang GM
    Asian Cardiovasc Thorac Ann; 2015 Feb; 23(2):140-5. PubMed ID: 24823382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis.
    Mohammadi S; Tchana-Sato V; Kalavrouziotis D; Voisine P; Doyle D; Baillot R; Sponga S; Metras J; Perron J; Dagenais F
    Circulation; 2012 Sep; 126(11 Suppl 1):S198-204. PubMed ID: 22965983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity.
    Waziri F; Karunanithi Z; Løgstrup BB; Hjortdal V; Nielsen PH; Poulsen SH
    J Cardiothorac Surg; 2019 Mar; 14(1):62. PubMed ID: 30885227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
    Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
    J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.